| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.085 | 0.02 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | -0.067 | 0.02 |
| mRNA | QS11 | GDSC1000 | pan-cancer | AAC | -0.081 | 0.02 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.072 | 0.02 |
| mRNA | CMK | GDSC1000 | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.02 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.02 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | -0.078 | 0.02 |
| mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | -0.076 | 0.02 |
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | -0.11 | 0.02 |